2025 Urgent Care Convention
Roche Diagnostics Near Patient Care at 2025 Urgent Care Convention
Join our Near Patient Care at Booth No. 405 during the 2025 Urgent Care Convention as we connect, learn and collaborate with industry leaders shaping the future of patient-centered Urgent Care. We’re excited to share how molecular infectious disease testing with cobas® liat can enhance point-of-care diagnostics, helping Urgent Care providers deliver faster, more reliable care.
Roche Diagnostics 2025 Urgent Care Convention Speaker Sessions
Join us for two insightful sessions exploring the power of molecular point-of-care diagnostics in urgent care—from enhancing infectious disease management to revolutionizing STI care in today’s evolving healthcare landscape.
Unlocking the Benefits of Molecular Point-of-Care Diagnostics for Infectious Disease Management in Urgent Care
Sunday, May 4, 2:30-3:15 p.m. CT in room De Soto
Dr. Jeannie Kenkare, Yale New Haven Health Urgent Care
As urgent care centers navigate the evolving landscape of infectious disease management, the implementation of molecular point-of-care (mPOC) diagnostics has become increasingly essential. This session will highlight one institution’s experience with mPOC testing, from implementation to impact.
Transforming STI Care: The Urgent Need for mPOC Testing in Today's Healthcare Landscape
Monday, May 5, 4:15-5:00 p.m. CT in room De Soto
Dr. Robyn Olney & Dr. Seamus Lonergan, Baylor Scott & White
With the U.S. witnessing a staggering 30% increase in reported cases of chlamydia, gonorrhea, and syphilis over the past five years, the escalating rates of sexually transmitted infections (STIs) present urgent public health challenges. Participants will discover how mPOC can empower urgent care centers to meet evolving patient demands and maintain a competitive edge in the healthcare landscape.
Convention Details
May 3-6, 2025
Hilton Anatole
2201 N Stemmons Fwy
Dallas, TX 75207
Booth No. 405
Product Spotlight
cobas® liat system
The cobas® liat system is a fully automated molecular system for the rapid analysis of individual samples and offers CLIA-waived assays for streamlined testing in various healthcare settings.